BERLIN (Reuters) – The European Union has exercised an option to acquire an additional 100 million doses of BioNTech and Pfizer’s COVID-19 vaccine, the two companies said on Monday.
This brings the total number of doses to be delivered to the 27 EU members to 600 million in 2021, the companies said in a statement.
(Reporting by Caroline Copley, editing by Kirsti Knolle)
Sign of the times: NCAA approves coach-to-player helmet communication for 2024 football season
Semyon Varlamov to start Game 1 for Islanders vs. Hurricanes
Cavaliers feel better prepared for playoff stage after ’23 flop, face Magic in first-round series
Olympic organizers unveil strategy for using artificial intelligence in sports
UConn freshman Stephon Castle declares for NBA draft and becomes school’s second one-and-done player
Seeking ‘the right side of history,’ Speaker Mike Johnson risks his job to deliver aid to UkrainePark it here: Is real estate in Manhattan always more expensive when it’s near a park?
Ukraine, Israel aid advances in rare House vote as Democrats help Republicans push it forwardFlorida man lights himself on fire outside Manhattan Criminal Courthouse amid Trump trial
Next UN climate talks are critical to plot aid for poorer nations, says incoming president
BNSF Railway says it didn’t know about asbestos that’s killed hundreds in Montana town
Soldiers who lost limbs in Gaza fighting are finding healing on Israel’s amputee soccer team
Emergency rooms refused to treat pregnant women, leaving one to miscarry in a lobby restroom
Nevada Supreme Court rulings hand setbacks to gun-right defenders and anti-abortion activists
